Search - tctmd.com

Displaying 281 - 300 of 654

Sort: Relevancy | Date

Presentation TCT 2017

Case Presentation 2: CTO Intervention

Presenter: Juan F. Granada, Roman Tarasov

October 29, 2017

Presentation TCT 2017

CTO: When to Open, When to Leave Alone

Presenter: Gary S. Mintz, Seung-Jung Park, Seung-Whan Lee

October 29, 2017

Presentation TCT 2017

Case #2: Primary PCI After Cardiac Arrest

Presenter: Juan Gustavo Del Angel Soto

October 29, 2017

Presentation TCT 2017

Clinical Case #1: The Limitless Potential of PCI

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Claudio M Cigalini

October 29, 2017

Presentation TCT 2017

Hemodynamic Support: Provisional vs Routine

Presenter: Amr Kamal, Mohamed Ahmed Sobhy, Mohamed Loutfi

October 29, 2017

Presentation TCT 2017

PCI Is More Than a Valid Alternative for Most Cases in Left Main and Multivessel Disease

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

How Would I Treat This Case?

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Jonathan M. Hill

October 29, 2017

Presentation TCT 2017

Minimalist Transfemoral TAVR: State-of-the-Art and Tips and Tricks

Presenter: Helene Eltchaninoff, Afzalur Rahman

October 29, 2017

Presentation TCT 2017

Lesion Preparation Considerations

Presenter: Amr Kamal, Mohamed Ahmed Sobhy, Mohamed Sadaka

October 29, 2017

Presentation TCT 2017

Case Presentation 1: Left Main Intervention

Presenter: Juan F. Granada, Narek Zakaryan

October 29, 2017

Presentation TCT 2017

How to Optimize Left Main and Bifurcation PCI: Secular Trends

Presenter: Gary S. Mintz, Seung-Jung Park, Duk-Woo Park

October 29, 2017

Presentation TCT 2017

Case #1: Rotablation and Coronary Perforation During a CTO Intervention

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Shih-Hsien Sung

October 29, 2017

Presentation TCT 2017

Welcome and Introductory Remarks

Presenter: Helene Eltchaninoff, Afzalur Rahman

October 29, 2017

Presentation TCT 2017

Case #1: Prehospital STEMI Treatment

Presenter: Jose L. Leiva-Pons, Jorge Guareña

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds Are Here to Stay!

Presenter: Antonio Colombo, Stephen G. Ellis, Ron Waksman

October 29, 2017

Presentation TCT 2017

Decision-making Process When Viewing a CHIP Case

Presenter: Amr Kamal, Mohamed Ahmed Sobhy

October 29, 2017

Presentation TCT 2017

Forty Years After the First PCI, Where Are We and Where Are We Headed?

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Spencer B. King III

October 29, 2017

Presentation TVT 2017

Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials

Presenter: Martin B. Leon, Hendrik Treede, Philippe Pibarot

June 16, 2017

Presentation TVT 2017

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani

June 16, 2017

Presentation TCT 2016

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Ganesh Manoharan

November 01, 2016

Advertisement

Case Presentation 2: CTO Intervention

CTO: When to Open, When to Leave Alone

Case #2: Primary PCI After Cardiac Arrest

Clinical Case #1: The Limitless Potential of PCI

Hemodynamic Support: Provisional vs Routine

PCI Is More Than a Valid Alternative for Most Cases in Left Main and Multivessel Disease

How Would I Treat This Case?

Minimalist Transfemoral TAVR: State-of-the-Art and Tips and Tricks

Lesion Preparation Considerations

Case Presentation 1: Left Main Intervention

How to Optimize Left Main and Bifurcation PCI: Secular Trends

Case #1: Rotablation and Coronary Perforation During a CTO Intervention

Welcome and Introductory Remarks

Case #1: Prehospital STEMI Treatment

Bioresorbable Scaffolds Are Here to Stay!

Decision-making Process When Viewing a CHIP Case

Forty Years After the First PCI, Where Are We and Where Are We Headed?

Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content